Emerging trends in transplantation of inherited metabolic diseases

被引：54
|
作者：
Prasad, V. K. [1 ]
Kurtzberg, J. [1 ]
机构：
[1] Duke Univ, Med Ctr, Pediat Blood & Marrow Transplant Program, Durham, NC 27710 USA
来源：
BONE MARROW TRANSPLANTATION | 2008年 / 41卷 / 02期
关键词：
inherited metabolic diseases; lysosomal and peroxisomal storage disease; hematopoietic stem cell transplantation; umbilical cord blood transplantation;
D O I：
10.1038/sj.bmt.1705970
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
Allogeneic hematopoietic stem cell transplantation (HSCT) can prolong life and improve its quality in patients with inherited metabolic diseases. HSCT offers a permanent source of enzyme replacement therapy and also might mediate nonhematopoietic cell regeneration or repair. Unrelated cord blood is an exciting newer graft source for treatment of patients with these fatal disorders, providing increased access to donors and significant clinical efficacy, particularly when transplantation is performed in early stages. Pre-transplant performance status is highly predictive of overall survival.
引用
收藏
页码：99 / 108
页数：10
相关论文
共 50 条
  • [31] Outcomes of pediatric liver transplantation in inherited metabolic diseases: a single-center's experience
    Yilmaz, T. U.
    Ertekin, V.
    Keceoglu, S.
    Ersoy, M.
    Ozer, A.
    Citak, A.
    Karakayali, H.
    Emiroglu, R.
    TRANSPLANTATION, 2022, 106 (8S) : 141 - 142
  • [32] Outcomes of Pediatric Liver Transplantation in Inherited Metabolic Diseases: A Single-center's Experience
    Ersoy, Melike
    Ertekin, Vildan
    Sik, Guntulu
    Citak, Agop
    Keceoglu, Selim
    Emiroglu, Remzi
    MEDICAL JOURNAL OF BAKIRKOY, 2022, 18 (01) : 94 - 100
  • [33] In utero hematopoietic stem cell transplantation: A caprine model for prenatal therapy in inherited metabolic diseases
    Lovell, KL
    Kraemer, SA
    Leipprandt, JR
    Sprecher, DJ
    Ames, NK
    Nichols-Torrez, J
    Carter, KD
    Rahmani, DK
    Jones, MZ
    FETAL DIAGNOSIS AND THERAPY, 2001, 16 (01) : 13 - 17
  • [34] Hematopoietic cell transplantation activity in Europe for inherited metabolic diseases: open issues and future directions
    A M Rovelli
    C G Steward
    Bone Marrow Transplantation, 2005, 35 : S23 - S26
  • [35] Reconstitution of lymphocyte subpopulations in children with inherited metabolic storage diseases after haematopoietic cell transplantation
    Corti, P
    Peters, C
    Balduzzi, A
    Bertagnolio, B
    Biondi, A
    Bugarin, C
    Dassi, M
    Furlan, F
    Gaipa, G
    Longoni, D
    Maglia, O
    Parini, R
    Perseghin, P
    Uderzo, C
    Uziel, G
    Masera, G
    Rovelli, A
    BRITISH JOURNAL OF HAEMATOLOGY, 2005, 130 (02) : 249 - 255
  • [36] SCREENING-TESTS FOR INHERITED METABOLIC DISEASES
    JONES, JD
    MAYO CLINIC PROCEEDINGS, 1984, 59 (05) : 347 - 349
  • [37] Respiratory manifestations in patients with inherited metabolic diseases
    Santamaria, Francesca
    Montella, Silvia
    Mirra, Virginia
    De Stefano, Sara
    Andria, Generoso
    Parenti, Giancarlo
    EUROPEAN RESPIRATORY REVIEW, 2013, 22 (130): : 437 - 453
  • [38] Systems for endogenous detoxification in inherited metabolic diseases
    Erasmus, E
    Reinecke, CJ
    FEBS JOURNAL, 2005, 272 : 121 - 122
  • [39] Antisense RNA therapy in inherited metabolic diseases
    Perez, B.
    Rincon, A.
    Aguado, C.
    Vega, A.
    Perez-Cerda, C.
    Merinero, B.
    Rodriguez-Pascau, L.
    Coll, M. J.
    Vilageliu, L.
    Grinberg, D.
    Desviat, L. R.
    Ugarte, M.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2008, 31 : 152 - 152
  • [40] THE DIAGNOSIS OF INHERITED METABOLIC DISEASES - NECESSITY OR LUXURY
    STOCKLER, S
    WIENER KLINISCHE WOCHENSCHRIFT, 1992, 104 (16) : 493 - 496
12345